Diabetic foot is a serious complication of diabetes which aggravates the patient's condition whilst also having significant socioeconomic impact. The aim of the present review is to summarize the causes and pathogenetic mechanisms leading to diabetic foot, and to focus on the management of this important health issue. Increasing physicians' awareness and hence their ability to identify the ''foot at risk,'' along with proper foot care, may prevent diabetic foot ulceration and thus reduce the risk of amputation.
INTRODUCTION
Diabetic foot is one of the most significant and devastating complications of diabetes, and is defined as a foot affected by ulceration that is associated with neuropathy and/or peripheral arterial disease of the lower limb in a patient with diabetes. The prevalence of diabetic foot ulceration in the diabetic population is 4-10%; more often lead to limb amputation [4] . It has been found that 40-70% of all nontraumatic amputations of the lower limbs occur in patients with diabetes [5] . Furthermore, many studies have reported that foot ulcers precede approximately 85% of all amputations performed in diabetic patients [5] .
The risk of foot ulceration and limb amputation increases with age and the duration of diabetes [6, 7] . The prevention of diabetic foot is crucial, considering the negative impact on a patient's quality of life and the associated economic burden on the healthcare system [8] .
Diabetic foot ulceration is a major health problem and its management involves a multidisciplinary approach. This review aims to provide a synopsis of the current management strategies of diabetic foot ulcers, from prevention to the options for treatment. The authors believe that it may be useful to primary care physicians, nurses, podiatrists, diabetologists, and vascular surgeons, as well as all healthcare providers involved in the prevention or management of diabetic foot ulcers.
PATHOGENESIS
The most significant risk factors for foot ulceration are diabetic neuropathy, peripheral arterial disease, and consequent traumas of the foot.
Diabetic neuropathy is the common factor in almost 90% of diabetic foot ulcers [9, 10] . Nerve damage in diabetes affects the motor, sensory, and autonomic fibers. Motor neuropathy causes muscle weakness, atrophy, and paresis. Sensory neuropathy leads to loss of the protective sensation of pain, pressure, and heat.
Autonomic dysfunction causes vasodilation and decreased sweating [11] , resulting in a loss of skin integrity, providing a site vulnerable to microbial infection [12] .
Peripheral arterial disease is 2-8 times more common in patients with diabetes, starting at an earlier age, progressing more rapidly, and usually being more severe than in the general population. It commonly affects the segments between the knee and the ankle. It has been proven to be an independent risk factor for cardiovascular disease as well as a predictor of the outcome of foot ulceration [13] . Even minor injuries, especially when complicated by infection, increase the demand for blood in the foot, and an inadequate blood supply may result in foot ulceration, potentially leading to limb amputation [14] . The majority of foot ulcers are of mixed etiology (neuroischemic), particularly in older patients [15] .
In patients with peripheral diabetic neuropathy, loss of sensation in the feet leads to repetitive minor injuries from internal (calluses, nails, foot deformities) or external causes (shoes, burns, foreign bodies) that are undetected at the time and may consequently lead to foot ulceration. This may be followed by infection of the ulcer, which may ultimately lead to foot amputation, especially in patients with peripheral arterial disease.
Structural foot deformities and abnormalities, such as flatfoot, hallux valgus, claw toes, Charcot neuroarthropathy, and hammer foot, play an important role in the pathway of diabetic foot ulcers since they contribute to abnormal plantar pressures and therefore predispose to ulceration. Other risk factors for foot ulceration include a previous history of foot ulceration or amputation, visual impairment, diabetic nephropathy, poor glycemic control, and cigarette smoking. Some studies have shown that foot ulceration is more common in men with diabetes than in women [14, 16] .
Social factors, such as low socioeconomic status, poor access to healthcare services, and poor education are also proven to be related to more frequent foot ulceration [14, 16] .
ASSESSMENT AND CLASSIFICATION
Physical examination of the diabetic foot is based on assessment of the skin and of the vascular, neurological, and musculoskeletal systems.
The dermatological examination includes a visual inspection of the skin of the legs and feet, particularly the dorsal, plantar, medial, lateral, and posterior surfaces, as well as a close examination of each toenail [17] . Other observations to be noted include the presence of peeling skin and maceration or fissuring of the interdigital skin. The visual inspection may discover signs of autonomic neuropathy and sudomotor dysfunction [17] .
People with diabetes are at high risk of developing peripheral vascular disease;
therefore, the palpation of pulses bilaterally in the dorsalis pedis, posterior tibial, popliteal, and superficial femoral arteries is necessary for assessment of the blood circulation in the lower limbs. Inadequate perfusion of a limb, due to peripheral vascular disease, may crucially affect the progress of the healing of an ulcer, often resulting in chronic unhealed ulcers that are susceptible to infection [15] . A relatively simple method to confirm the clinical suspicion of arterial occlusive disease is to measure the resting systolic blood pressure in the ankles and arms. This is performed by measuring the systolic blood pressure (using a Doppler probe) in the brachial, posterior tibial, and dorsalis pedis arteries [17] . Elevated temperature is reported to be associated with sudomotor dysfunction and a higher risk for foot ulceration [21, 22] . The presence of diabetic neuropathy can be established from an abbreviated medical history and physical examination. Symptoms such as a burning sensation; pins and needles; shooting, sharp, or stabbing pains; and muscle cramps, which are distributed symmetrically in both limbs (''stocking and glove distribution''), and often worse at night, are usually present in peripheral neuropathy. Diabetic peripheral neuropathy may also be evaluated using the Neuropathy Symptom Score (NSS), which is a validated symptom score with a high predictive value to screen for peripheral neuropathy in diabetes [23, 24] ( Table 1 ).
The physical examination of the foot assesses the perception of superficial pain (pinprick), temperature sensation (using a two-metal rod), light sensation (using the edge of a cotton-wool twist), and pressure (using the SemmesWeinstein 5.07 monofilament). Additionally, the physician should examine the vibration perception using a tuning fork and/or a biothesiometer. The examination of position sense (proprioception) and deep tendon reflexes (Achilles tendon, patellar) is also essential [4] .
Neuropathic deficits in the feet can be determined using the Neuropathy Disability Score (NDS), which is derived from the inability to detect pinprick sensation (using a neurological examination pin), vibration (using a 128-Hz tuning fork), or differences in temperature sensation (using warm and cool rods), and loss or reduction of the Achilles reflex (using a tendon hammer) [1] (Table 1) . According to the American Diabetes Association, a foot that has lost its protective sensation is considered to be a ''foot at risk'' for ulceration. The diagnosis of a foot at risk is confirmed by a positive 
TREATMENT
The gold standard for diabetic foot ulcer treatment includes debridement of the wound, management of any infection, revascularization procedures when indicated, and off-loading of the ulcer [28] . Other methods have also been suggested to be beneficial as add-on therapies, such as hyperbaric oxygen therapy, use of advanced wound care products, and negativepressure wound therapy (NPWT) [29] . However, data so far have not provided adequate evidence of the efficacy and cost-effectiveness of these add-on treatment methods.
Debridement
Debridement should be carried out in all chronic wounds to remove surface debris and necrotic tissues. It improves healing by promoting the production of granulation tissue and can be achieved surgically, enzymatically, biologically, and through autolysis.
Surgical debridement, known also as the ''sharp method,'' is performed by scalpels, and is rapid and effective in removing hyperkeratosis and dead tissue. Particular care should be taken to protect healthy tissue, which has a red or deep pink (granulation tissue) appearance [30] . Using a scalpel blade with the tip pointed at a 45°angle, all nonviable tissue must be removed until a healthy bleeding ulcer bed is produced with saucerization of the wound edges. If severe ischemia is suspected, aggressive debridement should be postponed until a vascular examination has been carried out and, if necessary, a revascularization procedure performed.
Enzymatic debridement can be achieved using a variety of enzymatic agents, including crab-derived collagenase, collagen from krill, papain, a combination of streptokinase and streptodornase, and dextrans. These are able to remove necrotic tissue without damaging the healthy tissue. Although expensive, enzymatic debridement is indicated for ischemic ulcers because surgical debridement is extremely painful in these cases [31] .
Biological debridement has been applied recently using sterile maggots. Maggots have the ability to digest surface debris, bacteria, and necrotic tissues only, leaving healthy tissue intact. Recent reports suggest that this method is also effective in the elimination of drugresistant pathogens, such as methicillinresistant Staphylococcus aureus, from wound surfaces [32] .
Autolytic debridement involves the use of dressings that create a moist wound environment so that host defense mechanisms (neutrophils, macrophages) can clear devitalized tissue using the body's enzymes. Autolysis is enhanced by the use of proper dressings, such as hydrocolloids, hydrogels, and films. Autolysis is highly selective, avoiding damage to the surrounding skin [33] .
In conclusion, debridement, especially the ''sharp method,'' is one of the gold standards in wound healing management, significantly contributing to the healing process of the wound, including the diabetic ulcer [34, 35] .
Off-loading
Off-loading of the ulcer area is extremely important for the healing of plantar ulcers. Retrospective and prospective studies have shown that elevated plantar pressures significantly contribute to the development of plantar ulcers in diabetic patients [36] [37] [38] . In addition, any existing foot deformities may increase the possibility of ulceration, especially in the presence of diabetic peripheral neuropathy and inadequate off-loading.
Furthermore, inadequate off-loading of the ulcer has been proven to be a significant reason for the delay of ulcer healing even in an adequately perfused limb [30] . The value of ulcer off-loading is increasing, as it has been reported that the risk of recurrence of a healed foot ulcer is high if the foot is not properly offloaded (in the high-pressure areas), even after closure of the ulcer [39] .
The most effective method of off-loading, which is also considered to be the gold standard, is the nonremovable total-contact cast (TCC). It is made of plaster or fast-setting fiberglass cast materials, has relatively low costs, and permits restricted activity [40] . Nonremovable TCCs are indicated for the effective off-loading of ulcers located at the forefoot or midfoot. Severe foot ischemia, a deep abscess, osteomyelitis, and poor skin quality are absolute contraindications to the use of a nonremovable TCC. Nonremovable TCCs work by distributing the plantar pressures from the forefoot and midfoot to the heel. They allow complete rest of the foot whilst also permitting restricted activity. Nonremovable TCCs also reduce edema, and compliance with treatment is necessarily high [40] .
There are a number of removable cast walkers (RCW), which usually have a lightweight, semirigid shell that helps support the limb whilst also providing full-cell protection (Fig. 1) [46, 47] . However, most of these studies were performed in wounds and not in diabetic ulcers [44, 46, 47] . Available data on their use in diabetes are scarce [35] , and therefore further randomized clinical trials are needed to support the existing evidence for their benefit in diabetic ulcers.
Growth Factors
PDGF-beta (becaplermin; available as Regranex Ò ; Ortho-McNeil Pharmaceutical, Inc., Titusville, NJ, USA; and Janssen-Cilag International NV, Beerse, Belgium) has been developed as a topical therapy for the treatment of noninfected diabetic foot ulcers. It is applied in the form of a once-daily gel along with debridement on a weekly basis [48] . Initial studies have indicated a significant positive effect of becaplermin [49, 50] on ulcer healing; however, more recent studies have reported an increased incidence of cancer in patients treated with becaplermin, especially at high doses [48] . Consequently, the US Food and Drug Administration has published a warning of an increased risk of cancer if more than three tubes of becaplermin are used [51] . Further studies are necessary in order to explore the benefit-to-risk ratio, as well as the cost effectiveness of this therapy.
Platelet-rich plasma (PRP) is an autologous product, extracted from the patient's plasma, which includes a high platelet concentration in Fig. 2 Off-loading of a diabetic foot ulcer with felted foam a fibrin clot that can be easily applied to the ulcer area. The fibrin clot is absorbed during wound healing within days to weeks following its application [52] . There are a few studies reporting a shorter closure time and higher healing percentage in patients using PRP and platelet-derived products [53, 54] . However, further studies are required to support the possible beneficial effect of this method in ulcer healing. The results of the subcutaneous administration of granulocyte colonystimulating factor (GCFS) in patients with infected foot ulcers vary, with some studies indicating faster resolution of the infection and faster healing [55, 56] , while others did not report any significant difference [57, 58] . Basic fibroblast growth factor (bFGF) is known to be beneficial in the formation of granulation tissue and normal healing [59] ; however, one small study failed to prove any significant difference between the intervention and the control group [60] . Epidermal growth factor (EGF) acts on epithelial cells, fibroblasts, and smooth muscle cells to promote healing [61] . Evidence for the use of EGF in diabetic ulcers is limited, with only a small amount of data reporting a significantly higher rate of ulcer healing with EGF use compared with placebo [62] . proinflammatory cytokines, and bacteria from the wound area [74] . It should be performed after debridement and continued until the formation of healthy granulation tissue at the surface of the ulcer. Currently, NPWT is indicated for complex diabetic foot wounds [74] ; however, it is contraindicated for patients with an active bleeding ulcer. Two small studies [75, 76] and one larger study [77] provide some encouraging data concerning the possible benefit of NPWT in the healing rate and time of diabetic foot ulcers. However, more randomized trials are needed in order to confirm these results.
Bioengineered Skin Substitutes

Hyperbaric Oxygen
There is strong evidence that fibroblasts, endothelial cells, and keratinocytes are replicated at higher rates in an oxygen-rich environment [78, 79] 
CONCLUSION
The management of diabetic foot ulcers remains a major therapeutic challenge which implies an urgent need to review strategies and treatments in order to achieve the goals and reduce the burden of care in an efficient and cost-effective way. Questions remain as to which types of intervention, technology, and dressing are suitable to promote healing, and whether all therapies are necessary and cost-effective as adjunctive therapies. The International
Working Group on the Diabetic Foot has conducted two systematic reviews [35, 83] of the evidence and effectiveness of interventions to enhance the healing of chronic diabetic foot ulcers. The preliminary results are promising, but large randomized controlled trials are necessary in order to establish the costeffectiveness of the new therapies. Prevention of diabetic foot ulceration is critical in order to reduce the associated high morbidity and mortality rates, and the danger of amputation. It is essential to identify the ''foot at risk,'' through careful inspection and physical examination of the foot followed by neuropathy and vascular tests.
Regular foot examination, patient education, simple hygienic practices, provision of appropriate footwear, and prompt treatment of minor injuries can decrease ulcer occurrence by 50% and eliminate the need for major amputation in nonischemic limbs [84, 85] . Diabetic foot ulcers should be carefully evaluated and the gold-standard treatments should be strictly applied in order to prevent amputation. Further clinical studies are needed to support the existing evidence regarding the clinical benefit of new approaches for the treatment of diabetic ulcers, and these approaches should be used only as add-on therapies to the gold-standard wound care.
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